Ligand Pharmaceuticals Incorporated opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Ligand Pharmaceuticals Incorporated

Patent Number:
Title:
Cyclodextrin
Opposition Date:
Jan 18, 2019
Patent Number:
Title:
A Method Of Producing An Antibody Comprising A Human Variable Region And A Rodent Constant Region.
Opposition Date:
Oct 31, 2018

Competitors of Ligand Pharmaceuticals Incorporated

CURADEV PHARMA PVT. LTD.

REGENERON PHARMACEUTICALS, INC.

Want to track Ligand Pharmaceuticals Incorporated?

Feel free to send us a message here and we will get back to you